-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $240

Benzinga·07/23/2026 17:23:43
Listen to the news
Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $235 to $240.